Skip to main navigation
Skip to search
Skip to main content
University of Johannesburg Home
Home
Scholars
Research entities
Research output
Press/Media
Equipment & facilities
Prestigious awards
Search by expertise, name or affiliation
Photobiomodulation for Alzheimer's disease: Has the light dawned?
Michael R. Hamblin
Massachusetts General Hospital
Harvard University
Harvard-MIT Division of Health Sciences and Technology
Research output
:
Contribution to journal
›
Review article
›
peer-review
87
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Photobiomodulation for Alzheimer's disease: Has the light dawned?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Photobiomodulation
100%
Clinical Trial
50%
Infrared Radiation
25%
Genetics
25%
Animal Model
25%
Tau
25%
Cognition
25%
Amyloid Beta
25%
Nursing and Health Professions
Alzheimer's Disease
100%
Inflammation
16%
Drug Therapy
16%
Malignant Neoplasm
16%
Disease
16%
Brain Disease
16%
Patient with Alzheimer's Disease
16%
Amyloid Plaque
16%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Clinical Trial
28%
Therapeutic Use
14%
Malignant Neoplasm
14%
Disease
14%
Inflammation
14%
Brain Disease
14%
Amyloid Plaque
14%
Keyphrases
Alzheimer's Dementia
50%
Amyloid Plaques
25%
Alzheimer's Disease Model
25%
Western World
25%
Shine
25%
Tau Tangles
25%
Neuroscience
Alzheimer's Disease
100%
Cognitive Function
14%
Beta Amyloid
14%